Erasca, Inc. (ERAS)
9.805
+0.18
(+1.92%)
USD |
NASDAQ |
Jan 20, 16:00
9.03
-0.78
(-7.90%)
After-Hours: 20:00
Erasca EPS Diluted (Quarterly): -0.1079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.0993 |
| Revolution Medicines, Inc. | -1.613 |
| Immuneering Corp. | -0.3772 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.61M |
| Total Expenses (Quarterly) | 30.61M |
| Enterprise Value | 2.489B |
| Earnings Yield | -4.60% |
| Normalized Earnings Yield | -4.358 |